Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Essential Medicinal Chemistry of Cannabidiol (CBD)
Kathryn M. Nelson, Jonathan Bisson, Gurpreet Singh, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 21, pp. 12137-12155
Open Access | Times Cited: 109

Showing 1-25 of 109 citing articles:

Cannabidiol inhibits SARS-CoV-2 replication through induction of the host ER stress and innate immune responses
Long C. Nguyen, Dongbo Yang, Vlad Nicolaescu, et al.
Science Advances (2022) Vol. 8, Iss. 8
Open Access | Times Cited: 113
Cannabis sativa terpenes are cannabimimetic and selectively enhance cannabinoid activity
Justin LaVigne, Ryan Hecksel, Attila Keresztes, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 88
Development of Stable Nano-Sized Transfersomes as a Rectal Colloid for Enhanced Delivery of Cannabidiol
Thope Moqejwa, Thashree Marimuthu, Pierre P. D. Kondiah, et al.
Pharmaceutics (2022) Vol. 14, Iss. 4, pp. 703-703
Open Access | Times Cited: 68
Cannabidiol Inhibits SARS-CoV-2 Replication and Promotes the Host Innate Immune Response
Long C. Nguyen, Dongbo Yang, Vlad Nicolaescu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 59
Medicinal Cannabis Prescribing in Australia: An Analysis of Trends Over the First Five Years
Sara L. Macphail, Miguel A. Bedoya‐Pérez, Rhys Cohen, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 40
Nanoformulations as a strategy to overcome the delivery limitations of cannabinoids
T. Srinivasa Reddy, Roby Zomer, Nitin Mantri
Phytotherapy Research (2023) Vol. 37, Iss. 4, pp. 1526-1538
Open Access | Times Cited: 39
Cannabidiol Alleviates Perfluorooctanesulfonic Acid-Induced Cardiomyocyte Apoptosis by Maintaining Mitochondrial Dynamic Balance and Energy Metabolic Homeostasis
Xixi Wang, Tong Xu, Dongliu Luo, et al.
Journal of Agricultural and Food Chemistry (2023) Vol. 71, Iss. 14, pp. 5450-5462
Closed Access | Times Cited: 35
Cannabidiol for the Treatment of Brain Disorders: Therapeutic Potential and Routes of Administration
Grace Tsz Yan Yau, Waiting Tai, Jonathon C. Arnold, et al.
Pharmaceutical Research (2023) Vol. 40, Iss. 5, pp. 1087-1114
Open Access | Times Cited: 26
Cannabidiol-Loaded Nanocarriers and Their Therapeutic Applications
Elham Assadpour, Atefe Rezaei, Sabya Sachi Das, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 4, pp. 487-487
Open Access | Times Cited: 23
Effect of saline irrigation and plant-based biostimulant application on fiber hemp (Cannabis sativa L.) growth and phytocannabinoid composition
Carmen Formisano, Nunzio Fiorentino, Ida Di Mola, et al.
Frontiers in Plant Science (2024) Vol. 15
Open Access | Times Cited: 8
Cannabidiol and Neurodegeneration: From Molecular Mechanisms to Clinical Benefits
Saurabh Kumar Jha, Vinod K. Nelson, Punna Rao Suryadevara, et al.
Ageing Research Reviews (2024) Vol. 100, pp. 102386-102386
Closed Access | Times Cited: 8
Cannabidiol - a friend or a foe?
Bianca-Maria Tihăuan, Tatiana Onisei, Walter Slootweg, et al.
European Journal of Pharmaceutical Sciences (2025), pp. 107036-107036
Open Access | Times Cited: 1
The emerging role of cannabidiol (CBD) products; a survey exploring the public's use and perceptions of CBD
Sukvinder Kaur Bhamra, Ankita Desai, Parmis Imani‐Berendjestanki, et al.
Phytotherapy Research (2021) Vol. 35, Iss. 10, pp. 5734-5740
Closed Access | Times Cited: 49
Cannabidiol inhibits SARS‐Cov‐2 spike (S) protein‐induced cytotoxicity and inflammation through a PPARγ‐dependent TLR4/NLRP3/Caspase‐1 signaling suppression in Caco‐2 cell line
Chiara Corpetti, Alessandro Re, Luisa Seguella, et al.
Phytotherapy Research (2021) Vol. 35, Iss. 12, pp. 6893-6903
Open Access | Times Cited: 48
Phase IIb Randomized, Placebo-Controlled, Dose-Escalating, Double-Blind Study of Cannabidiol Oil for the Relief of Symptoms in Advanced Cancer (MedCan1-CBD)
Janet Hardy, Ristan M. Greer, Georgie Huggett, et al.
Journal of Clinical Oncology (2022) Vol. 41, Iss. 7, pp. 1444-1452
Closed Access | Times Cited: 37
Cannabidiol (CBD) Dosing: Plasma Pharmacokinetics and Effects on Accumulation in Skeletal Muscle, Liver and Adipose Tissue
Robert B. Child, Mark J. Tallon
Nutrients (2022) Vol. 14, Iss. 10, pp. 2101-2101
Open Access | Times Cited: 36
A Comprehensive Phytochemical Analysis of Terpenes, Polyphenols and Cannabinoids, and Micromorphological Characterization of 9 Commercial Varieties of Cannabis sativa L.
Eugenia Mazzara, Jacopo Torresi, Gelsomina Fico, et al.
Plants (2022) Vol. 11, Iss. 7, pp. 891-891
Open Access | Times Cited: 32
Pharmacokinetics of cannabidiol following single oral and oral transmucosal administration in dogs
Giorgia Della Rocca, Fabiola Paoletti, Maria Beatrice Conti, et al.
Frontiers in Veterinary Science (2023) Vol. 9
Open Access | Times Cited: 16
Effects of Cannabidiol on Innate Immunity: Experimental Evidence and Clinical Relevance
Stefano De Martini, Alessandra Gemma, Marco Ferrari, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3125-3125
Open Access | Times Cited: 16
Identification of a New Family of Prenylated Volatile Sulfur Compounds in Cannabis Revealed by Comprehensive Two-Dimensional Gas Chromatography
Iain W. H. Oswald, Marcos A. Ojeda, Ryan J. Pobanz, et al.
ACS Omega (2021) Vol. 6, Iss. 47, pp. 31667-31676
Open Access | Times Cited: 34
Cannabidiol and Cannabigerol Inhibit Cholangiocarcinoma Growth In Vitro via Divergent Cell Death Pathways
Michael J. Viereckl, Kelsey Krutsinger, Aaron K. Apawu, et al.
Biomolecules (2022) Vol. 12, Iss. 6, pp. 854-854
Open Access | Times Cited: 25
Cannabinoid-mediated targeting of mitochondria on the modulation of mitochondrial function and dynamics
R.F. Malheiro, Helena Carmo, Félix Carvalho, et al.
Pharmacological Research (2022) Vol. 187, pp. 106603-106603
Open Access | Times Cited: 25
Comparative Pharmacokinetics of Commercially Available Cannabidiol Isolate, Broad-Spectrum, and Full-Spectrum Products
Erin C. Berthold, Shyam H. Kamble, Raju S. Kanumuri, et al.
European Journal of Drug Metabolism and Pharmacokinetics (2023) Vol. 48, Iss. 4, pp. 427-435
Closed Access | Times Cited: 15
Pharmacokinetics behavior of four cannabidiol preparations following single oral administration in dogs
Sasithorn Limsuwan, Natthaporn Phonsatta, Atikorn Panya, et al.
Frontiers in Veterinary Science (2024) Vol. 11
Open Access | Times Cited: 5
Utilization of Cannabidiol in Post-Organ-Transplant Care
Sachiko Koyama, Jumar Etkins, Jin-Sun Jun, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 699-699
Open Access
Page 1 - Next Page

Scroll to top